Use of collagen biostimulators in orofacial harmonization
DOI:
https://doi.org/10.11606/issn.2357-8041.clrd.2020.165832Keywords:
Dermal Fillers, Collagen, Calcium Hydroxyapatite, Polymethyl Methacrylate, Collagen biostimulatorAbstract
This study briefly addresses the facial aging process, reviews, and discusses the use of collagen biostimulators used in orofacial harmonization in search of facial rejuvenation. Methods: Articles published until 2019 in SciELO, BIREME and PubMed in English and Brazilian Portuguese were verified. The inclusion criteria were: original articles that analyze or discuss skin fillers with biostimulatory capacity, and the facial aging process. A total of 72 articles that met the inclusion criteria was found. Discussion: In the dermatological market there are four skin fillers (poly-L-lactic acid, calcium hydroxyapatite, polycaprolactone and polymethylmethacrylate) that have the mechanism of action of stimulating neocolagenesis by localized subclinical inflammatory response from the host. Each product has its particularities as to its composition, onset time, and durability. According to the literature, they are generally considered to be effective and safe, and can be used by properly trained professionals. Conclusion: Collagen biostimulators are excellent materials with the ability to prevent or reverse the effects of the facial aging process. However, there is still no perfect dermal biostimulator, as everyone can be associated with adverse effects, and the professional must know how to select the ideal product for treating each patient.
Downloads
References
Papazian MF, Silva LM, Crepaldi AA, Crepaldi MLS, Aguiar AP. Principais aspectos dos preenchedores faciais. Revista Faipe. 2018;8(1):101-16.
Conselho Federal de Odontologia (BR). Resolução nº 198, de 29 de janeiro de 2019. Reconhece a Harmonização Orofacial como especialidade odontológica, e dá outras providências. Diário Oficial da União [Internet]. 2019 Jan 31 [cited 2020 May 5];22:91. Disponível em: https://bit.ly/3foEVeD
Coimbra DD, Uribe NC, Oliveira BS. “Quadralização facial” no processo do envelhecimento. Surg Cosmet Dermatol. 2014;6(1):6571.
Franzen JM, Santos JMSR, Zancanaro V. Colágeno: uma abordagem para a estética. RIES. 2013 Sept;2(2):49-61. doi: https://doi.org/10.33362/ries.v2i2.161.
Miranda LHS. Ácido poli-L-lático e hidroxiapatita de cálcio: melhores indicações. In: Lyon S, Silva RC. Dermatologia estética: medicina e cirurgia estética. Rio de Janeiro: MedBook; 2015. p. 267-80
Monteiro EO, Parada MOB. Preenchimentos faciais – parte um. Rev Bras Med. 2010 jul;67(Suppl 4):6-4.
Sharabi SE, Hatef DA, Koshy JC. Mechanotransduction: the missing link in the facial aging puzzle? Aesth Plast Surg. 2010;34(5):603-11. doi: https://doi.org/10.1007/s00266-010-9519-5.
Fitzgerald R, Vleggaar D. Facial volume restoration of the aging face with poly-L-lactic aciddth. Dermatol Ther. 2011 Jan-Feb;24:2-27. doi: https://doi.org/10.1111/j.1529-8019.2010.01375.x.
Attenello NH, Maas CS. Injectable fillers: review of material and properties. Facial Plast Surg. 2015;31:29-34. doi: https://doi.org/10.1055/s-0035-1544924.
Avelar LE, Cazerta CE. The improvement of the skin quality with the use of PLLA. J Dermat Cosmetol. 2018;2(2):101-2. doi: https://doi.org/10.15406/jdc.2018.02.00052.
Flores IC, González JLM. Materiales de relleno en dermatología. Dermatología CMQ. 2011 Oct;9(4):275-83.
Lam SM, Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg. 2006;118(3 Suppl.):55S-63S. doi: https://doi.org/10.1097/01.prs.0000234612.20611.5a.
Bentkover SH. The biology of facial fillers. Facial Plast Surg. 2009;25(2):73-85. doi: https://doi.org/10.1055/s-0029-1220646
Tagle JM, Macchetto PC, Páramo RMD. Clinical performance of a dermal filler containing natural glycolic acid and a polylactic acid polymer. J Clin Aesthetic Dermatol. 2010 Feb;3(2):42-7.
Beer K. Dermal fillers and combinations of fillers for facial rejuvenation. Dermatol Clin. 2009 Oct;27(4):427-32. doi: https://doi.org/10.1016/j.det.2009.08.011.
Lacombe V. Sculptra: a stimulatory filler. Facial Plast Surg. 2009;25(2):95-99. doi: https://doi.org/10.1055/s-0029-1220648
Fabi SG, Goldman MP. The safety and efficacy of combining poly-L-lactic acid with intense pulsed light in facial rejuvenation: a retrospective study of 90 patients. Dermatol Surg. 2012;38:1208-16. doi: https://doi.org/10.1111/j.1524-4725.2012.02476.x
Schierle CF, Casas LA. Nonsurgical rejuvenation of the aging face with injectable poly-L-lactic acid for restoration of soft tissue volume. Aesthet Surg J. 2011 Jan;31(1):95-109. doi: https://doi.org/10.1177/1090820X10391213.
Satini RM, Silva F, Cardoso GF. Uso do ácido poli-L-láctico como restaurador de volume facial. Rev Bras Cir Plást. 2013;28(2):223-6.
Sherman RN. Sculptra: the New Three-Dimensional Filler. Clin Plastic Surg. 2006;33(4):539-50. doi: https://doi.org/10.1016/j.cps.2006.09.001.
Rendon MI. Long-term aesthetic outcomes with injectable poly-L-lactic acid: observations and practical recommendations based on clinical experience over 5 years. J Cosmet Dermatol. 2012;11,93-100.
Williams DF. On the mechanisms of biocompatibility. Biomaterials. 2008;29(20):2941-53. doi: https://doi.org/10.1016/ j.biomaterials.2008.04.023.
Machado Filho CDS, Santos TC, Rodrigues APLJM, Cunha MG. PolyLlactic acid: a biostimulating agent. Surg Cosmet Dermatol. 2013;5(4):34550.
Narins RS. Minimizing Adverse Events Associated with poly-L-lactic acid injection. Dermatol Surg. 2008;34(S1):S100-4. doi: https://doi.org/10.1111/j.1524-4725.2008.34250.x.
Goldberg D, Guana A, Volk A, Daro-Kaftan E. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg. 2013;39(6):915-22. doi: https://doi.org/10.1111/dsu.12164
Donis AA, Gutiérrez PG, Domínguez NR, Moreno GS, Ávila JR. Revisión de materiales de relleno. Dermatología CMQ. 2015;13(1):54-64.
Haddad A, Kadunc BV, Guarnieri C, Noviello JS, Cunha MG, Parada MB. Conceitos atuais no uso do ácido poli-L-láctico para rejuvenescimento facial: revisão e aspectos práticos. Surg Cosmet Dermatol. 2017;9(1):60-71. doi: https://doi.org/10.5935/scd1984-8773.201791952
Dermik Laboratories (US) .Sculptra [bula]. Bridgewater; 2009.
Mitchel P, Goldman MP. Cosmetic use of poly-L-lactic acid: my technique for success and minimizing complications. Dermatol Surg. 2011;37(5):688-93. doi: https://doi.org/10.1111/j.1524-4725.2011.01975.x
Greco TM, Antunes MB, Yellin SA. Injectable fillers for volume replacement in the aging face. Facial Plast Surg. 2012;28:8-20. doi: https://doi.org/10.1055/s-0032-1305786
Bassichis B, Blick G, Cnant M, Condoluci D, Echavez M, Eviatar J, et al. Injectable poly-L-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES). Dermatol Surg. 2012;38(7 Pt 2):1193-205. doi: https://doi.org/10.1111/j.1524-4725.2012.02474.x
Sadick NS, Palmisano L. Case study involving use of injectable poly-L-lactic acid (PLLA) for acne scars. J Dermatolog Treat. 2009;20(5):302-7. doi: https://doi.org/10.1080/09546630902817879.
Requena L, Requena C, Christensen L, Zimmermann US, Kutzner H, Cerroni L. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol. 2011;64(1):1-34. doi: https://doi.org/10.1016/j.jaad.2010.02.064
Alam M, Gladstone H, Krame EM, Murphy JP, Nouri K, Neuhaus IM, et al. Guidelines of care: injectable fillers. Dermatol Surg. 2008;34(Suppl 1):S115-48. doi: https://doi.org/10.1111/j.1524-4725.2008.34253.x.
Daines SM, Williams EF. Complications associated with injectable soft-tissue fillers. JAMA Facial Plast Surg. 2013;15(3):226-31. doi: https://doi.org/10.1001/jamafacial.2013.798.
Beer K, Avelar R. Relationship between delayed reactions to dermal fillers and biofilms: facts and considerations. Dermatol Surg. 2014;40:1175-9 doi: https://doi.org/10.1097/01.DSS.0000452646.76270.53.
Lemperle G, Gauthier-Hazar N, Wolters M, Eisemann-Klein M, Zimmermann U, Duffy DM. Foreign body granulomas after all injectable dermal fillers: part 1. possible causes. Plast Reconstr Surg. 2009;123(6):1842-63. doi: https://doi.org/10.1097/PRS.0b013e31818236d7.
Agência Nacional de Vigilância Sanitária (BR). Consulta de produtos para saúde [Internet]. Brasília, DF; 2019 [cited 2019 Oct 25]. Disponível em: https://consultas.anvisa.gov.br.
Loghem JV, Yutskovskaya YA, Werschler P. Calcium hydroxylapatite: over a decade of clinical experience. J Clin Aesthet Dermatol. 2015;8(1):38-49.
Goldie K, Peeters W, Alghoul M, Butterwick K, Casabona G, Chao YYY, et al. Global consensus guidelines for the injection of diluted and hyperdiluted calcium hydroxylapatite for skin tightening. Dermatol Surg. 2018;44(Suppl 1):S32-41. doi: https://doi.org/10.1097/DSS.0000000000001685.
Jacovella PF. Use of calcium hydroxylapatite (Radiesse®) for facial augmentation. Clin Interv Aging. 2008;3(1):161-74.
Berlin AL, Hussain M, Goldberg DJ. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg. 2008;34(Suppl 1):S64-7. doi: https://doi.org/10.1111/j.1524-4725.2008.34245.x.
Yutskovskay Y, Kogan E, Leshunov E. A randomized, split-face, histomorphologic study comparing a volumetric calcium hydroxylapatite and a hyaluronic acid-based dermal filler. J Drugs Dermatol. 2014;13(9):47-52.
Sundaram H, Voigts B, Beer K, Meland M. Comparison of the rheological properties of viscosity and elasticity in two categories of soft tissue fillers: calcium hydroxylapatite and hyaluronic acid. Dermatol Surg. 2010 Nov;36(Suppl 3):1859-65. doi: https://doi.org/10.1111/j.1524-4725.2010.01743.x
Rauso R, Curinga G, Rusciani A, Colella G, Amore R, Tartaro G. safety and efficacy of one-step rehabilitation of human immunodeficiency virus-related facial lipoatrophy using an injectable calcium hydroxylapatite dermal filler. Dermatol Surg. 2013;39(12):1887-94. doi: https://doi.org/10.1111/dsu.12358
Carruthers A, Carruthers J. evaluation of injectable calcium hydroxylapatite for the treatment of facial lipoatrophy associated with human immunodeficiency virus. Dermatol Surg. 2008;34(11):1486-99. doi: https://doi.org/10.1111/j.1524-4725.2008.34323.x
Treacy P. J. Dermall filler treatment for atrofic acne scarring. Prime [Internet]. 2013 Mar [cited 2019 Oct 25]. Disponível em: https://www.linkedin.com/pulse/calcium-hydroxylapatite-treatment-acne-scarring-dr-patrick-j-treacy/
Dadzie OE, Mahalingam M, Parada M, El Helou T, Philips T, Bhawan J. Adverse cutaneous reactions to soft tissue fillers – a review of the histological features. J Cutan Pathol. 2008;35(6):536-48. doi: https://doi.org/10.1111/j.1600-0560.2007.00853.x
Kim JA, Abel DV. Neocollagenesis in human tissue injected with a polycaprolactone-based dermal filler. J Cosmet Laser Ther. 2015;17(2):99-101. doi: https://doi.org/10.3109/14764172.2014.968586
Goodwin P. Collagen stimulation with a range of polycaprolactone dermal fillers. JAN. 2018 Out;7(Suppl 2):22-8. doi: https://doi.org/10.12968/joan.2018.7.Sup2.22
Galadari H, Abel D, Nuami KA, Faresi FA, Galadari I. A randomized, prospective, blinded, split-face, single-center study comparing polycaprolactone to hyaluronic acid for treatment of nasolabial folds. J Cosmet Dermatol. 2015 Mar;14(1):27-32. doi: https://doi.org/10.1111/jocd.12126
Moers-Carpi MM, Sherwood S. Polycaprolactone for the correction of nasolabial folds: a 24-month, prospective, randomized, controlled clinical trial. Dermatol Surg. 2013;39(3):457-63. doi: https://doi.org/10.1111/dsu.12054
Figueiredo VM. A five-patient prospective pilot study of a polycaprolactone based dermal filler for hand rejuvenation. J Cosmet Dermatol. 2013 Mar;12(1):73-7. doi: https://doi.org/10.1111/jocd.12020
Kwon T, Han SW, Yeo IK, Kim JH, Kim JM, Hong JY, et al. Biostimulatory effects of polydioxanone, poly‐d, l lactic acid, and polycaprolactone fillers in mouse model. J Cosmet Dermatol. 2019;18(4):1002-8. doi: https://doi.org/10.1111/jocd.12950
Pitt CG, Chasalow FI, Hibionada YM, Klimas DM, Schindler A. Aliphatic polyesters. I. The degradation of poly (e-caprolactone) in vivo. J Ap Pol Science. 1981;26(11):3779-87. doi: https://doi.org/10.1002/app.1981.070261124
Sun H, Mei L, Song C, Cui X, Wang P. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials. 2006;27:1735-40. doi: https://doi.org/10.1016/j.biomaterials.2005.09.019
Bae B, Lee G, Oh S, Hong K. Safety and long-term efficacy of forehead contouring with a polycaprolactone-based dermal filler. Dermatol Surg. 2016;42(11):1256-60. doi: https://doi.org/10.1097/DSS.0000000000000913
Melo F, Marijnissen-Hofste J. Investigation of physical properties of a polycaprolactone dermal filler when mixed with lidocaine and lidocaine/epinephrine. Dermatol Ther. 2012;2:1-13. doi: https://doi.org/10.1007/s13555-012-0013-7
Melo F, Nicolau P, Piovano L, Lin S, Baptista-Fernandes T, King MI, et al. Recommendations for volume augmentation and rejuvenation of the face and hands with the new generation polycaprolactone-based collagen stimulator (Ellansé®). Clin Cosmet Investig Dermatol. 2017;8(10):431-40. doi: https://doi.org/10.2147/CCID.S145195
Lin SL. Polycaprolactone facial volume restoration of a 46-year-old Asian women: A case report. J Cosmet Dermatol. 2018;17(3):328-32. doi: https://doi.org/10.1111/jocd.12482
Skrzypek E, Górnicka B, Skrzypek DM, Krzysztof MR. Granuloma as a complication of polycaprolactone-based dermal filler injection: ultrasound and histopathology studies, Journal of Cosmetic and Laser Therapy. J Cosmet Laser Ther. 2019;21(2):65-8. doi: https://doi.org/10.1080/14764172.2018.1461229
Lemperle G, Knapp TR, Sadick NS, Lemperle SM. ArteFill permanent injectable for soft tissue augmentation: I. Mechanism of action and injection techniques. Aesth Plast Surg. 2010;34:264-72. doi: https://doi.org/10.1007/s00266-009-9413-1
Lemperle G, Sadick NS, Knapp TR, Lemperle SM. ArteFill permanent injectable for soft tissue augmentation: II. indications and applications. Aesth Plast Surg. 2010;34:273-86. doi: https://doi.org/10.1007/s00266-009-9414-0
Lemperle G, Morhenn VB, Pestonjamasp V, Gallo RL. Migration studies and histology of injectable microspheres of different sizes in mice. Plast Reconstr Surg. 2004 Apr;15:113(5):1380-90. doi: https://doi.org/10.1097/01.prs.0000112764.22839.7a
Cohen SR, Berner CF, Busso M, Gleason MC, Hamilton D, Holmes R, et al. ArteFill: A long-lasting injectable wrinkle filler material-summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes. Plast Reconstr Surg. 2006 ;118 (3 Suppl):64S-76S. doi: https://doi.org/10.1097/01.prs.0000234873.00905.a4
Lebon Laboratório. Linnea Safe [bula]. Porto Alegre; 2018.
Vargas AF, Amorim NG, Pintaguy I. Complicações tardias dos preenchimentos permanentes. Rev. Bras. Cir. Plást. 2009 Jan-Mar; 24(1):71-81.
Dornelas MT, Corrêa MPD, Netto GM, Barra FML, Alves SGS, Dornelas MC, et al. Bioplastia na lipodistrofia de pacientes com HIV/AIDS. Rev. Bras. Cir. Plást. 2012;27(3):387-91.
Kurimori KT, Mendes M, Milcheski DA, Monteiro AA, Gemperli R. Complicação grave do uso irregular do PMMA: relato de caso e a situação brasileira atual. Rev. Bras. Cir. Plást. 2019;34(1):156-162. doi: https://doi.org/10.5935/2177-1235.2019RBCP0025
Parada MB, Cazerta C, Afonso JPJM, Nascimento DLS. Manejo de complicações de preenchedores dérmicos. Surg Cosmet Dermatol. 2015;8(4):342-51. doi: https://doi.org/10.5935/scd1984-8773.201684897
Ibrahim O, Dover JS. Delayed-Onset nodules after polymethyl methacrylate injections. Dermatol Surg. 2017;44(9):1236-8. doi: https://doi.org/10.1097/DSS.0000000000001405
Bringel DM, Bomm L, Azevedo AC, Souto R, Fonseca JC. Complicação de preenchimento cutâneo após tratamento de hepatite C com interferon e ribavirina. Surg Cosmet Dermatol. 2012;4(3):271-3.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Natália Barbosa de Lima, Marilia de Lima Soares
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are requested to send, together with the letter to the Editors, a term of responsibility. Thus, the works submitted for appreciation for publication must be accompanied by a document containing the signature of each of the authors, the model of which is presented as follows:
I/We, _________________________, author(s) of the work entitled_______________, now submitted for the appreciation of Clinical and Laboratorial Research in Dentistry, agree that the authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Date: ____/____/____Signature(s): _______________
